Home » Previous Page » News Item:

Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution

Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution


Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulate

Continue ...

 PDF
Tags:   Recalls    Par    Pharmaceutical    Issues    Voluntary    Nationwide    Recall    One    Lot    Treprostinil    Injection    Due    Potential    for    Silicone    Particulates    the    Product    Solution
Rating: 0.00 (0 votes) Rate this article
Bookmark and share this news item: